Risk of multiple drug-drug interactions (DDIs) in HCV patients receiving pangenotypic DAAs (pDAAs): A complex drug interaction scenario first time evaluated in German patients

被引：0
|
作者：
Umland, Tim [1 ]
Hintz, Andreas [1 ]
Niess, Gero [2 ]
Guendogdu, Mehtap [2 ]
Tacke, Frank [3 ]
机构：
[1] Alexander Apotheke, Hamburg, Germany
[2] Gilead Sci GmbH, Planegg, Germany
[3] Charite Campus Mitte, Med Klin MS Hepatol & Gastroenterol, Berlin, Germany
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-377
引用
收藏
页码：S793 / S793
页数：1
相关论文
共 50 条
  • [41] Risk and Cost Associated With Drug-Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France
    Demessine, Ludivine
    Peyro-Saint-Paul, Laure
    Gardner, Edward M.
    Ghosn, Jade
    Parienti, Jean-Jacques
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (03):
  • [42] Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C
    Turnes, J.
    Garcia-Herola, A.
    Morillo, R.
    Mendez, M.
    Rueda, M.
    Hernandez, C.
    Sicras-Mainar, A.
    Freismuth, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 42 - 42
  • [43] Drug-drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease
    Kuper, JJ
    D'Aprile, M
    CLINICAL PHARMACOKINETICS, 2000, 39 (03) : 203 - 214
  • [44] RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C
    Turnes, Juan
    Garcia, Antonio
    Morillo-Verdugo, Ramon
    Mendez, Marinela
    Rueda, Magdalena
    Hernandez, Candido
    Sicras-Mainar, Antoni
    HEPATOLOGY, 2021, 74 : 574A - 575A
  • [45] Drug-Drug Interactions of Clinical Significance in the Treatment of Patients with Mycobacterium avium Complex Disease
    Jeffrey J. Kuper
    Michelle D’Aprile
    Clinical Pharmacokinetics, 2000, 39 : 203 - 214
  • [46] Evaluating the Impact of polypharmacy and drug-drug interactions on Cognitive performance of Multiple Sclerosis patients
    Jahani, Shima
    Rezaei, Ali
    Hamidi, Majid
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1044 - 1044
  • [47] Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
    Bachmann, Paula
    Frahm, Niklas
    Debus, Jane Louisa
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Streckenbach, Barbara
    Baldt, Julia
    Heidler, Felicita
    Hecker, Michael
    Zettl, Uwe Klaus
    PHARMACEUTICS, 2022, 14 (03)
  • [48] Analysis of risk for side effects due to drug-drug and drug-gene interactions in a cohort of patients with Complex Regional Pain Syndrome
    Jain, Sameer
    Danesh, Arash
    Cruciani, Ricardo
    Maxwell, Christina
    Bakhtiari, Saba
    Laroche, Marcus
    NEUROLOGY, 2017, 88
  • [49] Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors
    Bibi, Rashida
    Azhar, Saira
    Iqbal, Ayesha
    Jabeen, Hajera
    Kalsoom, Umm-e
    Iqbal, Muhammad M.
    Nazeer, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1616 - 1622
  • [50] Risk factors for contraindicated potential drug-drug interactions in acute intracerebral hemorrhage patients
    Aleksic, D.
    Toncev, G.
    Drakulic, S. Miletic
    Milosavljevic, M.
    Jankovic, S.
    Stefanovic, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 363 - 363
12345